B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”

Oct.10.2025
B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”
British Columbia, Canada is advancing what it calls the world’s first e-cigarette Public Health Accountability law, granting the government authority to sue companies for “deceptive marketing.” The move puts public-health risks at the center of vaping industry compliance.

Key Takeaways
 

· First-of-its-kind legislation: British Columbia, Canada is proposing the world’s first public-health accountability bill for e-cigarettes, bringing public-health risks squarely into the regulatory framework.

 

· Focus on “deceptive marketing”: Targets practices such as hiding ingredients and downplaying addictiveness, with a particular emphasis on youth-oriented marketing.

 

· Modeled on tobacco & opioid litigation: Enables the government to initiate or join class actions to recover public-health costs.

Potential North American ripple effects: If passed, it could become a template for vaping oversight and raise compliance thresholds across the industry.

 


2Firsts, October 10, 2025 — According to Canadian media reports, the Government of British Columbia (B.C.) is advancing a new bill designed to make it easier for the province to sue e-cigarette companies over “misleading or deceptive” marketing.

 

At an October 9 press conference, Attorney General Niki Sharma said the vaping sector “targets young people in specific ways,” including failing to fully disclose product ingredients and the risks of nicotine addiction. “This bill will give the government more direct legal tools to address potential harms in the public-health realm,” she said.

 

 

Modeled on Tobacco and Opioid Suits

 

 

Sharma noted the bill mirrors laws that previously allowed governments to seek recovery of public-health costs from tobacco and opioid manufacturers. “We want a framework that lets the government launch similar class actions—or join related cases in other jurisdictions.”

 

If adopted, it would be the first law explicitly holding the vaping industry to account for public-health impacts. It would not automatically penalize companies; the government would still need to bring suit.

 

 

Forthcoming Legislative Agenda

 

 

B.C. also plans to introduce another bill in the spring session addressing environmental and health liabilities for manufacturers of PFAS (“forever chemicals”).

 

Sharma highlighted mounting health controversies among certain occupational groups—particularly firefighters—and noted multiple lawsuits are underway.

 

 

Damages Benchmarks & Industry Fallout

 

 

It remains unclear whether vaping companies could absorb large judgments. As a party to past tobacco litigation, B.C. is set to receive C$3.6 billion over 18 years from a settlement totaling C$32.5 billion. Opioid-related cases are ongoing.

 

Rob Cunningham of the Canadian Cancer Society pointed out that several U.S. cases involving Juul have settled, and a proposed class action is before the Supreme Court of British Columbia. He warned that “vaping is becoming a primary gateway to nicotine dependence among youth,” while long-term health effects remain uncertain.

 

“Evidence on the harms of smoking took decades to establish; research on vaping could take at least 25 years,” Cunningham said. “But if this bill passes, it may change corporate marketing behavior in the meantime.”

 

 

Policy Extensions & Regulatory Trends

 

 

Beyond legislation, B.C. is expanding youth vaping-prevention education. Some public-health groups are urging the province to raise the legal purchase age for vaping products to 21 and to ban flavored products.

 

The bill’s progress could become a landmark in North American regulation of vaping marketing and public-health accountability, with knock-on effects for global compliance standards in novel nicotine products.

 

 

Cover image caption: B.C. Attorney General Niki Sharma, photographed Wednesday, October 8, 2025. Source: Flickr / Government of British Columbia.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
Philip Morris International (PMI) has confirmed plans to bring its IQOS heated tobacco device to Argentina by the end of 2026, after the Argentine government lifted long-standing restrictions and created a regulatory framework for heated tobacco, e-cigarettes and nicotine pouches.
News
Jun.26 by 2Firsts Perspectives
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Global’s Nasdaq debut under ticker AIIR ended with a 18.6% first-day decline, giving the global hookah industry a rare public-market reference point. Beyond one company’s share move, the listing raises a broader question: can a culturally rooted, fragmented and venue-based category evolve into a more scalable and investable consumer sector?
Special Report
May.19
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Frank Vandenbroucke described the tobacco industry as a “criminal” sector with “no future” during an appearance on VRT’s current affairs program Ter Zake. His comments came after Belgium’s Constitutional Court ruled that a government ban on cigarette and vape sales in supermarkets was discriminatory because it allowed small shops to sell tobacco products while prohibiting larger retailers from doing so.
May.07 by 2FIRSTS.ai